Afuco™ Anti-Human GRN ADCC Therapeutic Antibody, ADCC Enhanced

Anti-GRN ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a neutralizing anti-GP88 antibody, inhibits GP88 biological effect (proliferation and migration) in a dose-dependent fashion in vitro, used for treating breast cancer.
Supplier Creative Biolabs
Product # AFC-319CL
Pricing Inquiry
Host Human
Target GRN
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Feedback